Risk factors and anti-HBc reactivity among first time blood donors

Vox Sanguinis

Volumn 72, Issue 4, 1997, Pages 207-210

  Molijn, M H J ^a   Van Der Linden, J M ^a   Ko, L K ^a   Gorgels, J ^a   Hop, W ^a   Van Rhenen, D J ^a,b,c  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; MARKER;

ADULT; ANAMNESIS; ANTIGEN ANTIBODY REACTION; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; DIAGNOSTIC VALUE; HEPATITIS C; HEPATITIS NON A NON B; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SERODIAGNOSIS; SPOUSE; VIRUS TRANSMISSION;

EID: 0031000226     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.1997.7240207.x     Document Type: Article

References (12)

1. Cossart YE, Kirsch S, Ismay SL: Posttransfusion hepatitis in Australia. Report of the Australian Red Cross study. Lancet 1992;1:208-213.
2. Stevens CE, Aack RD, Hollinger FB, et al: Hepatitis B virus antibody in blood donors and the occurrence of non-A, non B-hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study. Ann Intern Med 1984;101:733-738.
3. Koziol DE, Holland PV, Alling DW, et al: Antibody to hepatitis B core antigen as a paradoxal marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med 1986;104:488-495.
4. Alter HJ, Jet BW, Polito AJ, et al: Analysis of the role of hepatitis C virus in transfusion-associated hepatitis, in Hollinger FB, Lemon SM, Margolis HS (eds): Viral Hepatitis and Liver Diseases. Baltimore, Williams & Wilkins, 1991, pp 396-402.
5. Chambers LA, Popovsky MA: Decrease in repeated posttransfusion hepatitis. Contribution of donor screening for alanine aminotransferase and antibodies to hepatitis B cor antigen and changes in the general population. Arch Intern Med 1991;151:2445-2448.
6. Jullien AM, Couroncé AM, Massari V, et al: Impact of screening donor blood for alanine aminotransferase and antibody to hepatitis B core antigen on the risk of hepatitis C virus transmission. Eur J Clin Microbiol Infect Dis 1993;12: 668-672.
7. Blajchman MA, Bull SB, Feinman SV, et al: Post-tranfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests. Lancet 1995; 345:21-25.
8. Mosley JW, Stevens CE, Aach RD, et al: Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion 1995;35:5-12.
9. Zaaijer HL, ter Borg F, Cuypers HTM, et al: Comparison of methods for detection of hepatitis B virus DNA. J Clin Microb 1994;32:2088-2091.
10. Anderson JA: Diagnosis by logistic discriminant function. Appl Stat 1974;23:397-404.
11. Carman WF, Korula J, Wallace L: Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg Elisa. Lancet 1995;345:1406-1407.
12. Hughes W, Barr A, Dow BC, et al: A multicentre assessment of the specificity of ten anti-HBc screening tests. Transfus Med 1995;5: 225-230.